Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT

Bone Marrow Transplantation volume 47, pages 1201–1205 (2012)Cite this article

Subjects

Abstract

To investigate the health-related quality of life (HRQoL) of patients receiving allogeneic hematopoietic SCT (allo-HSCT) from HLA-haploidentical/partially matched related donors (HID/PMRD) and to compare this value with that of patients receiving allo-HSCT from HLA-identical sibling donor (ISD), a total of 350 patients receiving allo-HSCT were enrolled in a study (ISD: 173; HID/PMRD: 177). HRQoL post transplantation was evaluated by an SF-36 questionnaire. The effect of various factors on the HRQoL was analyzed through COX regression. Compared with the ISD group, patients in the HID/PMRD group had higher scores in physical functioning, general health, bodily pain, vitality and emotional role functioning, and these patients functioned significantly better on the physical and mental component summaries. Also, long-term survivors exhibit better HRQoL. Measured by multivariate analysis, extensive chronic GVHD was observed to have a strongly negative impact on patients’ HRQoL, while male gender status, lower age when receiving allo-HSCT and returning to work or school were associated with positive impacts on at least one subscale. These results showed that the HRQoL of patients receiving HID/PMRD hematopoietic SCT (HSCT) is comparable to that of patients receiving ISD HSCT, and HLA disparity is not the factor affecting the HRQoL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 2006; 38: 291–297.

    Article  PubMed  Google Scholar 

  2. Han W, Lu DP, Huang XJ, Liu KY, Chen H, Xu LP et al. Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases. Zhonghua Xue Ye Xue Za Zhi 2004; 25: 453–457.

    PubMed  Google Scholar 

  3. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004; 104: 1898–1906.

    Article  CAS  PubMed  Google Scholar 

  4. Wong FL, Francisco L, Togawa K, Bosworth A, Gonzales M, Hanby C et al. Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns. Blood 2010; 115: 2508–2519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Fraser CJ, Bhatia S, Ness K, Carter A, Francisco L, Arora M et al. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867–2873.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kopp M, Schweigkofler H, Holzner B, Nachbaur D, Niederwieser D, Fleischhacker WW et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27–32.

    Article  CAS  PubMed  Google Scholar 

  7. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129–1136.

    Article  CAS  PubMed  Google Scholar 

  8. Duell T, van Lint MT, Ljungman P, Tichelli A, Socié G, Apperley JF et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med 1997; 126: 184–192.

    Article  CAS  PubMed  Google Scholar 

  9. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.

    Article  CAS  PubMed  Google Scholar 

  10. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.

    Article  CAS  PubMed  Google Scholar 

  11. Chiodi S, Spinelli S, Ravera G, Petti AR, Van Lint MT, Lamparelli T et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614–619.

    Article  CAS  PubMed  Google Scholar 

  12. Bieri S, Roosnek E, Helg C, Verholen F, Robert D, Chapuis B et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008; 42: 819–827.

    Article  CAS  PubMed  Google Scholar 

  13. Bush NE, Haberman M, Donaldson G, Sullivan KM . Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med 1995; 40: 479–490.

    Article  CAS  PubMed  Google Scholar 

  14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  15. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  16. Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A . Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33 (suppl): AS264–AS279.

    PubMed  Google Scholar 

  17. Li L, Wang HM, Shen Y . Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health 2003; 57: 259–263.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619–626.

    Article  CAS  PubMed  Google Scholar 

  19. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL . The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant 2010; 45: 746–754.

    Article  CAS  PubMed  Google Scholar 

  20. Higman MA, Vogelsang GB . Chronic graft versus host disease. Br J Haematol 2004; 125: 435–454.

    Article  PubMed  Google Scholar 

  21. Teshima T, Matsuo K, Matsue K, Kawano F, Taniguchi S, Hara M et al. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors. Br J Haematol 2005; 130: 575–587.

    Article  PubMed  Google Scholar 

  22. Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006; 107: 3065–3073.

    Article  CAS  PubMed  Google Scholar 

  23. Chen XH, Gao L, Zhang X, Gao L, Zhang C, Kong PY et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation. Blood Cell Mol Dis 2009; 43: 98–104.

    Article  CAS  Google Scholar 

  24. Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A et al. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group. Bone Marrow Transplant 2005; 35: 1011–1018.

    Article  CAS  PubMed  Google Scholar 

  25. Bacigalupo A, Lamparelli T, Barisione G, Bruzzi P, Guidi S, Alessandrino PE et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006; 12: 560–565.

    Article  PubMed  Google Scholar 

  26. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942–2947.

    Article  CAS  PubMed  Google Scholar 

  27. Temple RO, Carvalho J, Tremont G . A national survey of physicians’ use of and satisfaction with neuropsychological services. Arch Clin Neuropsychol 2006; 21: 371–382.

    Article  PubMed  Google Scholar 

  28. Paller AS, McAlister RO, Doyle JJ, Jackson A . Perceptions of physicians and pediatric patients about atopic dermatitis, its impact, and its treatment. Clin Pediatr (Phila) 2002; 41: 323–332.

    Article  Google Scholar 

  29. Byrne NM, Hardy L . Community physiotherapy for children with cystic fibrosis: a family satisfaction survey. J Cyst Fibros 2005; 4: 123–127.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partly supported by the National Outstanding Young Scientist's Foundation of China (Grant No. 30725038), Program for Innovative Research Team in University (Grant No. IRT 0702). This manuscript had been edit by Matthew Bayer, PhD of American Journal Experts.

Author information

Authors and Affiliations

  1. Peking University People's Hospital, Institute of Hematology, Beijing, PR China

    X-D Mo, L-P Xu, D-H Liu, Y-H Chen, W Han, X-H Zhang, H Chen, Y Wang, J-Z Wang, K-Y Liu & X-J Huang

Authors
  1. X-D Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L-P Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D-H Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y-H Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. X-H Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J-Z Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K-Y Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. X-J Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to X-J Huang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mo, XD., Xu, LP., Liu, DH. et al. Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT. Bone Marrow Transplant 47, 1201–1205 (2012). https://doi.org/10.1038/bmt.2011.250

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.250

Keywords

This article is cited by

Search

Advanced search

Quick links